The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils - PubMed (original) (raw)
. 1992 Jul 15;149(2):599-608.
Affiliations
- PMID: 1378071
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
M Columbo et al. J Immunol. 1992.
Abstract
The gene product of the steel locus of the mouse represents a growth factor for murine mast cells and a ligand for the c-kit proto-oncogene receptor, a member of the tyrosine kinase receptor class of oncogenes (for review, see O. N. Witte. 1990. Cell 63:5). We have studied the effect of the human recombinant c-kit receptor ligand stem cell factor (rhSCF) on the release of inflammatory mediators from human skin mast cells and peripheral blood basophils and compared its activity to that of rhIL-3, rhSCF (1 ng/ml to 1 microgram/ml) activated the release of histamine and PGD2 from mast cells isolated from human skin. Analysis by digital video microscopy indicated that purified human skin mast cells (84 +/- 5% pure) responded to rhSCF (0.1 to 1 microgram/ml) challenge with a rapid, sustained rise in intracellular Ca2+ levels that was accompanied by secretion of histamine. A brief preincubation (10 min) of mast cells with rhSCF (0.1 pg/ml to 1 ng/ml) significantly enhanced (100 +/- 35%) the release of histamine induced by anti-IgE (3 micrograms/ml), but was much less effective on IgE-mediated release of PGD2. In contrast, a short term incubation with rhSCF did not potentiate the secretion of histamine activated by substance P (5 microM). A 24-h incubation of mast cells with rhSCF did not affect the release of mediators induced by anti-IgE (3 micrograms/ml), probably due to receptor desensitization, rhSCF (1 ng/ml to 3 micrograms/ml) neither caused release of histamine or leukotriene C4 (LTC4) release from leukocytes of 14 donors, nor induced a rise in intracellular Ca2+ levels in purified (greater than 70%) basophils. Brief preincubation (10 min) of leukocytes with rhSCF (1 ng/ml to 3 micrograms/ml) caused an enhancement (69 +/- 11%) of anti-IgE-induced release of histamine that was significant at concentrations as low as 3 ng/ml (p less than 0.05), whereas it appeared less effective in potentiating IgE-mediated LTC4 release. In contrast, a prolonged incubation (24 h) with rhSCF (0.1 pg/ml to 100 ng/ml) did not enhance the release of histamine or LTC4 induced by anti-IgE (0.1 microgram/ml), whereas rhIL-3 (3 ng/ml) significantly potentiated the release of both mediators.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G. Casolaro V, et al. J Pharmacol Exp Ther. 1993 Dec;267(3):1375-85. J Pharmacol Exp Ther. 1993. PMID: 7505332 - Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V, Casolaro V, Björck L, Marone G. Patella V, et al. J Immunol. 1990 Nov 1;145(9):3054-61. J Immunol. 1990. PMID: 1698870 - Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
Marone G, Stellato C, Mastronardi P, Mazzarella B. Marone G, et al. Ann Fr Anesth Reanim. 1993;12(2):116-25. doi: 10.1016/s0750-7658(05)81020-2. Ann Fr Anesth Reanim. 1993. PMID: 7690200 Review. - Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J, Ohanyan T, Church MK, Maurer M, Metz M. Gericke J, et al. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1832-6. doi: 10.1111/jdv.12693. Epub 2014 Sep 26. J Eur Acad Dermatol Venereol. 2015. PMID: 25257818 Review.
Cited by
- Citreorosein inhibits degranulation and leukotriene C₄ generation through suppression of Syk pathway in mast cells.
Lu Y, Li Y, Jahng Y, Son JK, Chang HW. Lu Y, et al. Mol Cell Biochem. 2012 Jun;365(1-2):333-41. doi: 10.1007/s11010-012-1273-3. Epub 2012 Mar 1. Mol Cell Biochem. 2012. PMID: 22395859 - Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.
Fonteh AN, Samet JM, Chilton FH. Fonteh AN, et al. J Clin Invest. 1995 Sep;96(3):1432-9. doi: 10.1172/JCI118179. J Clin Invest. 1995. PMID: 7544805 Free PMC article. - Reversible expansion of primate mast cell populations in vivo by stem cell factor.
Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG. Galli SJ, et al. J Clin Invest. 1993 Jan;91(1):148-52. doi: 10.1172/JCI116164. J Clin Invest. 1993. PMID: 7678600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous